Report Description

Forecast Period

2024-2028

Market Size (2022)

USD 19.52 billion

CAGR (2023-2028)

7.65%

Fastest Growing Segment

Minimally Invasive

Largest Market

North America


Market Overview

Global Vasectomy Market has valued at USD 19.52 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.65% through 2028. The global vasectomy market refers to the industry involved in the provision of vasectomy services and related products. Vasectomy is a surgical procedure used for permanent male contraception, where the vas deferens, the tubes that carry sperm from the testicles, are cut or sealed.

Key Market Drivers

Increasing Awareness and Education

In recent years, the global vasectomy market has experienced a significant surge in growth, and a pivotal driving force behind this expansion is the increasing awareness and education regarding vasectomy as a viable method of contraception. This growing awareness is changing the way individuals and couples perceive family planning, making vasectomy an attractive choice for those seeking a reliable, permanent contraceptive solution.

Historically, vasectomy was surrounded by misconceptions and myths, leading to apprehensions and reluctance among potential candidates. However, concerted efforts by healthcare organizations, governments, and advocacy groups have helped demystify vasectomy. These initiatives focus on providing accurate information about the procedure, its safety, and the fact that it does not affect a man's sexual performance or libido. As a result, individuals and couples are now more informed about the realities of vasectomy, which has contributed to its growing acceptance.

Education and awareness campaigns have played a crucial role in promoting family planning as a whole. When individuals and couples are educated about their contraceptive options, they are better equipped to make informed choices that suit their unique needs and circumstances. Vasectomy, as a permanent and highly effective method of contraception, is presented as a viable option in these campaigns. This promotes the idea that family planning is a shared responsibility and encourages couples to consider vasectomy as a means of taking an active role in family planning decisions.

In some cultures, and societies, there has been a stigma associated with vasectomy due to misconceptions and a lack of understanding. However, increased awareness and education campaigns have helped combat this stigma by portraying vasectomy as a responsible and practical choice. Men and couples are now more willing to discuss vasectomy openly, which reduces the social stigma associated with the procedure and encourages its adoption.

Awareness campaigns often highlight the accessibility and availability of vasectomy services. Individuals who may have previously been unaware of where to obtain a vasectomy or how to navigate the process are now guided towards appropriate healthcare providers. This improved accessibility, combined with knowledge, encourages more individuals to consider vasectomy as a viable contraceptive option.

Many governments and public health organizations actively support and promote family planning as part of their public health agendas. These initiatives often include educational programs and subsidies for vasectomy procedures. When individuals are aware of these programs and their benefits, they are more likely to take advantage of the financial incentives and make informed choices about family planning methods.

Changing Gender Dynamics

The global vasectomy market is experiencing a significant upsurge in growth, and one of the key driving forces behind this expansion is the changing dynamics in gender roles and responsibilities within relationships. In an era marked by increased gender equality and shared decision-making in families, vasectomy has emerged as a crucial component of the conversation surrounding contraception.

Traditionally, family planning and contraception have primarily been the responsibility of women. However, changing gender dynamics have led to a more equitable sharing of this responsibility. Couples today are more likely to engage in open and honest discussions about contraception, seeking options that involve both partners. Vasectomy, as a contraceptive method that directly involves men, provides couples with an opportunity to actively participate in family planning decisions, reflecting a more balanced approach to gender roles.

Vasectomy aligns with women's empowerment by offering them more choices in family planning. When both partners participate in the decision-making process, women are better able to consider their own health, career goals, and personal aspirations. Vasectomy can provide women with a sense of security, knowing that they have a reliable, permanent contraception option that is not solely dependent on their bodies.

Shared decision-making in family planning can strengthen emotional connections between partners. Couples who engage in open dialogues about contraception, including vasectomy, tend to report higher levels of trust, communication, and mutual understanding. Vasectomy discussions can foster emotional intimacy and reinforce the idea that family planning decisions are a shared endeavor.

Changing gender dynamics also extends to economic considerations. As more women enter the workforce and pursue their careers, families are increasingly looking for contraceptive options that allow them to manage their family size effectively without compromising financial stability. Vasectomy offers an attractive solution in this regard, as it is a one-time expense that eliminates ongoing costs associated with other contraceptive methods.

Vasectomy can alleviate some of the healthcare burdens traditionally placed on women. Many forms of contraception, such as birth control pills and intrauterine devices (IUDs), require women to manage their reproductive health actively. Vasectomy eliminates the need for women to take daily or periodic contraceptive measures, thereby reducing the healthcare burden on them.

Changing gender dynamics emphasize the importance of equal partnerships in all aspects of life, including family planning. Vasectomy is a practical embodiment of this principle, demonstrating that both partners have an equal say in decisions that impact their shared future. As such, it contributes to more egalitarian relationships, aligning with the values of many modern couples.

Cost-Effectiveness

The global vasectomy market is witnessing substantial growth, and a significant driver behind this expansion is the cost-effectiveness of this permanent male sterilization procedure. Vasectomy offers an affordable and long-term solution to contraception, making it an attractive choice for individuals and couples seeking a reliable and economical family planning option.

Vasectomy is renowned for its cost-effectiveness in the long run. Unlike many other contraceptive methods, which require ongoing expenses such as monthly prescriptions or the purchase of contraceptives, vasectomy incurs a one-time cost. Once the procedure is completed, there are no further expenses related to contraception. This makes it an attractive choice for individuals and couples looking to minimize the financial burden of family planning over time.

When comparing vasectomy to other contraceptive options available, it often emerges as a more cost-effective choice. Birth control pills, condoms, intrauterine devices (IUDs), and other methods can incur substantial recurring costs over several years. In contrast, vasectomy offers a permanent solution at a fraction of the cost, making it a budget-friendly choice for those who seek both reliability and affordability.

From a broader perspective, the cost-effectiveness of vasectomy extends beyond individual or family budgets. It also benefits healthcare systems and society as a whole. Fewer unintended pregnancies mean reduced healthcare costs associated with prenatal care, childbirth, and neonatal care. Governments and healthcare providers recognize the economic advantages of promoting vasectomy as a means of population control, which contributes to the growth of the vasectomy market.

Couples who opt for vasectomy often experience significant cost savings in the long term. By eliminating the need for continuous contraceptive measures, they can allocate their resources to other essential aspects of their lives, such as education, homeownership, or investments. The financial stability that vasectomy provides can positively impact the overall well-being of couples and their families.

In some regions, health insurance plans cover vasectomy procedures, making it an even more cost-effective choice for individuals and couples. Additionally, governments in certain countries offer subsidies or incentives to encourage men to undergo vasectomy as part of their family planning efforts. These financial incentives further reduce the financial barrier to vasectomy adoption.

Improved Surgical Techniques

The global vasectomy market is experiencing remarkable growth, driven by a pivotal factor - advancements in surgical techniques. Vasectomy, a procedure for permanent male contraception, has evolved significantly over the years, becoming less invasive, safer, and more accessible.

The introduction of the no-scalpel vasectomy technique has revolutionized the field of male sterilization. Unlike traditional vasectomy, which involves the use of scalpels and sutures, the no-scalpel approach uses a small puncture to access the vas deferens. This minimally invasive technique reduces pain, discomfort, and the risk of complications. As a result, more men are willing to consider vasectomy, contributing to the market's growth.

Improved surgical techniques have prioritized patient comfort and post-operative recovery. No-scalpel vasectomy, for instance, typically involves less pain and discomfort during and after the procedure. This leads to shorter recovery times, allowing individuals to return to their normal activities sooner. The reduced fear of discomfort and inconvenience encourages more men to choose vasectomy as a viable contraception option.

Advancements in surgical techniques have also led to a decrease in complication rates associated with vasectomy. Traditional vasectomy procedures carried a slightly higher risk of complications, such as infection or hematoma. The adoption of non-scalpel vasectomy and other minimally invasive approaches has significantly reduced the likelihood of these issues, enhancing patient safety and confidence.

Improved surgical techniques have streamlined the vasectomy procedure, reducing the time it takes to complete. No-scalpel vasectomy, in particular, is known for its efficiency and precision, allowing healthcare providers to perform the surgery more quickly. Shorter procedure times not only benefit patients by minimizing the time spent in the clinic but also increases the overall capacity of healthcare facilities to perform vasectomies, making them more accessible.

Advancements in surgical techniques have improved the precision of vasectomy procedures. This precision is critical in ensuring the success of the operation, as it reduces the likelihood of recanalization, a rare but potential issue where the vas deferens can rejoin, rendering the procedure ineffective. Higher success rates bolster the confidence of both healthcare providers and patients in vasectomy as a reliable contraceptive method.


Download Free Sample Report

Key Market Challenges

Cultural Stigma and Misconceptions

One of the foremost challenges in the global vasectomy market is the persistence of cultural stigma and misconceptions surrounding the procedure. In some societies, vasectomy is still associated with emasculation or concerns about sexual performance. Misunderstandings about the procedure's reversibility or its impact on masculinity deter potential candidates. Addressing these misconceptions through education and awareness campaigns is crucial to overcoming this challenge.

Access to Healthcare

Access to healthcare services, particularly in underserved or rural areas, remains a significant challenge for the vasectomy market. In many regions, there is a lack of trained healthcare providers who can perform vasectomies. Additionally, the affordability and availability of vasectomy services can be barriers for individuals and couples. Efforts to expand access to vasectomy, especially in resource-limited settings, are essential to overcome this challenge.

Alternative Contraceptive Methods

The availability of alternative contraceptive methods, such as condoms, birth control pills, and intrauterine devices (IUDs), can compete with vasectomy. Individuals and couples may choose these methods because they are familiar, readily available, or perceived as less invasive. Convincing them of the long-term benefits and cost-effectiveness of vasectomy can be a challenge.

Public Funding and Incentives

In some countries, the lack of public funding or incentives for vasectomy can deter men from considering the procedure. While vasectomy is cost-effective in the long term, the initial expense can be a barrier. Governments and healthcare systems need to evaluate the potential benefits of offering subsidies or incentives to promote vasectomy as part of family planning efforts.

Key Market Trends

Minimally Invasive Techniques

While minimally invasive techniques, such as non-scalpel vasectomy, have already gained traction, ongoing research and innovation are expected to further refine these approaches. Continued improvements in surgical techniques will lead to even shorter recovery times, reduced discomfort, and fewer complications, making vasectomy an even more attractive choice for potential candidates.

Eco-Friendly Family Planning

Environmental considerations are gaining prominence in family planning discussions. Vasectomy's status as an environmentally friendly contraception method, by reducing the carbon footprint associated with other contraceptives, will align with the values of individuals and couples who prioritize sustainability.

Customized Counseling and Decision Support

Personalized counseling and decision support tools are likely to emerge, helping individuals and couples make informed choices about contraception. These tools may include digital platforms that assess a person's preferences, values, and circumstances to provide tailored information and recommendations.

Global Expansion of Services

Efforts to expand vasectomy services globally are expected to continue. Organizations and healthcare providers will work to ensure that vasectomy services are available in more regions, including underserved and remote areas, to meet the growing demand.

Segmental Insights

Type Insights

In 2022, the global vasectomy market is expected to be largely dominated by conventional vasectomy methods due to their well-established reputation for efficacy and cost-effectiveness. Patients and healthcare providers alike continue to place trust in these tried-and-true techniques. However, looking ahead to the forecast period, we anticipate a notable rise in the adoption of minimally invasive vasectomy procedures. This trend can be attributed to the growing demand for quicker recovery times, reduced pain, and decreased risk of complications, which minimally invasive methods offer. As patient awareness and preferences evolve, so too will the vasectomy market, with minimally invasive procedures likely gaining momentum in the coming years.

End-User Insights

In 2022, Hospitals & Clinics are poised to maintain their dominance in the Global Vasectomy Market, and this trend is expected to persist during the forecast years. Hospitals & Clinics are well positioned to lead the market due to their reputation for providing comprehensive and specialized healthcare services. Patients often choose these established healthcare facilities for vasectomy procedures due to the assurance of professional expertise and access to state-of-the-art equipment and facilities. Moreover, the association with hospitals and clinics instills confidence in patients regarding the safety and quality of care. This trust factor, combined with the convenience of having the procedure performed within a healthcare setting, is likely to ensure the continued dominance of Hospitals & Clinics in the Global Vasectomy Market in the years to come.


Download Free Sample Report

Regional Insights

  • North America is poised to dominate the Global Vasectomy Market for several compelling reasons. Firstly, the region boasts a highly developed healthcare infrastructure, including a multitude of specialized clinics and hospitals offering vasectomy services. This accessibility ensures that patients have easy access to the procedure. Secondly, North America has a robust healthcare insurance system, often covering vasectomy costs, making it more affordable for a broader population. Additionally, the region has a culture of healthcare awareness and openness to family planning, contributing to the high demand for vasectomy procedures. Finally, North America benefits from a well-established network of experienced healthcare professionals, including urologists and surgeons, who can perform vasectomies with precision and expertise. Collectively, these factors position North America as the dominant force in the Global Vasectomy Market.

Key Market Players

  • Pfizer Inc
  • Bristol Myers Squibb SA
  • Teva Pharmaceuticals USA Inc
  • Upsher-Smith Laboratories Inc
  • SMITHFIELD BIOSCIENCE
  • Opocrin SPA
  • Bioiberica SA
  • GSK PLC
  • Johnson & Johnson Consumer Inc
  • Fresenius SE & Co KGaA

 By Type

By Patient

By End-User

By Region

  • Conventional
  • Minimally Invasive
  • No-Scalpel
  • Animal
  • Human
  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

 

Report Scope:

In this report, the Global Vasectomy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Vasectomy Market, By Type:

o   Conventional

o   Minimally Invasive

o   No-Scalpel

  • Vasectomy Market, By Patient:

o   Animal

o   Human

  • Vasectomy Market, By End-User:

o   Hospitals & Clinics

o   Ambulatory Care Centers

o   Others

  • Vasectomy Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  Germany

§  United Kingdom

§  France

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  Japan

§  India

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vasectomy Market.

Available Customizations:

Global Vasectomy market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Vasectomy Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]                

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Vasectomy Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Type (Conventional, Minimally Invasive, No-Scalpel)

5.2.2.    By Patient (Animal, Human)

5.2.3.    By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)

5.2.4.    By Region

5.2.5.    By Company (2022)

5.3.  Product Market Map

5.3.1.    By Type

5.3.2.    By Patient

5.3.3.    By End-User

5.3.4.    By Region

6.    North America Vasectomy Market Outlook

6.1.  Market Size & Forecast       

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Type (Conventional, Minimally Invasive, No-Scalpel)

6.2.2.    By Patient (Animal, Human)

6.2.3.    By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)

6.2.4.    By Country

6.3.  North America: Country Analysis

6.3.1.    United States Vasectomy Market Outlook

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.           By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.           By Type

6.3.1.2.2.           By Patient

6.3.1.2.3.           By End-User

6.3.2.    Canada Vasectomy Market Outlook

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.           By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.           By Type

6.3.2.2.2.           By Patient

6.3.2.2.3.           By End-User

6.3.3.    Mexico Vasectomy Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.           By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.           By Type

6.3.3.2.2.           By Patient

6.3.3.2.3.           By End-User

7.    Europe Vasectomy Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Type (Conventional, Minimally Invasive, No-Scalpel)

7.2.2.    By Patient (Animal, Human)

7.2.3.    By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)

7.2.4.    By Country

7.3.  Europe: Country Analysis

7.3.1.    Germany Vasectomy Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           By Type

7.3.1.2.2.           By Patient

7.3.1.2.3.           By End-User

7.3.2.    United Kingdom Vasectomy Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           By Type

7.3.2.2.2.           By Patient

7.3.2.2.3.           By End-User

7.3.3.    France Vasectomy Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           By Type

7.3.3.2.2.           By Patient

7.3.3.2.3.           By End-User

7.3.4.    Italy Vasectomy Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.           By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.           By Type

7.3.4.2.2.           By Patient

7.3.4.2.3.           By End-User

7.3.5.    Spain Vasectomy Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.           By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.           By Type

7.3.5.2.2.           By Patient

7.3.5.2.3.           By End-User

8.    Asia-Pacific Vasectomy Market Outlook

8.1.  Market Size & Forecast       

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Type (Conventional, Minimally Invasive, No-Scalpel)

8.2.2.    By Patient (Animal, Human)

8.2.3.    By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)

8.2.4.    By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.    China Vasectomy Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           By Type

8.3.1.2.2.           By Patient

8.3.1.2.3.           By End-User

8.3.2.    Japan Vasectomy Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           By Type

8.3.2.2.2.           By Patient

8.3.2.2.3.           By End-User

8.3.3.    India Vasectomy Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           By Type

8.3.3.2.2.           By Patient

8.3.3.2.3.           By End-User

8.3.4.    Australia Vasectomy Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.           By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.           By Type

8.3.4.2.2.           By Patient

8.3.4.2.3.           By End-User

8.3.5.    South Korea Vasectomy Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.           By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.           By Type

8.3.5.2.2.           By Patient

8.3.5.2.3.           By End-User

9.    South America Vasectomy Market Outlook

9.1.  Market Size & Forecast       

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Type (Conventional, Minimally Invasive, No-Scalpel)

9.2.2.    By Patient (Animal, Human)

9.2.3.    By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)

9.2.4.    By Country

9.3.  South America: Country Analysis

9.3.1.    Brazil Vasectomy Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           By Type

9.3.1.2.2.           By Patient

9.3.1.2.3.           By End-User

9.3.2.    Argentina Vasectomy Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           By Type

9.3.2.2.2.           By Patient

9.3.2.2.3.           By End-User

9.3.3.    Colombia Vasectomy Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           By Type

9.3.3.2.2.           By Patient

9.3.3.2.3.           By End-User

10. Middle East and Africa Vasectomy Market Outlook

10.1.             Market Size & Forecast        

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. By Type (Conventional, Minimally Invasive, No-Scalpel)

10.2.2. By Patient (Animal, Human)

10.2.3. By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)

10.2.4. By Country

10.3.             MEA: Country Analysis

10.3.1. South Africa Vasectomy Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Type

10.3.1.2.2.         By Patient

10.3.1.2.3.         By End-User

10.3.2. Saudi Arabia Vasectomy Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Type

10.3.2.2.2.         By Patient

10.3.2.2.3.         By End-User

10.3.3. UAE Vasectomy Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Type

10.3.3.2.2.         By Patient

10.3.3.2.3.         By End-User

10.3.4. Kuwait Vasectomy Market Outlook

10.3.4.1.     Market Size & Forecast

10.3.4.1.1.         By Value

10.3.4.2.     Market Share & Forecast

10.3.4.2.1.         By Type

10.3.4.2.2.         By Patient

10.3.4.2.3.         By End-User

11. Market Dynamics

11.1.             Drivers

11.2.             Challenges

12. Market Trends & Developments

12.1.             Recent Development

12.2.             Mergers & Acquisitions

12.3.             Product Launches

13. Porter’s Five Forces Analysis

13.1.             Competition in the Industry

13.2.             Potential of New Entrants

13.3.             Power of Suppliers

13.4.             Power of Customers

13.5.             Threat of Substitute Products

14. Competitive Landscape

14.1.             Business Overview

14.2.             Product Offerings

14.3.             Recent Developments

14.4.             Financials (As Reported)

14.5.             Key Personnel

14.6.             SWOT Analysis

14.6.1.  Pfizer Inc

14.6.2.  Bristol Myers Squibb SA

14.6.3.  Teva Pharmaceuticals USA Inc

14.6.4.  Upsher-Smith Laboratories Inc

14.6.5.  SMITHFIELD BIOSCIENCE

14.6.6.  Opocrin SPA

14.6.7.  Bioiberica SA

14.6.8.  GSK PLC

14.6.9.  Johnson & Johnson Consumer Inc

14.6.10.                Fresenius SE & Co KGaA

15.   Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Global Vasectomy Market was estimated to be USD 19.52 billion in 2022.

down-arrow

Pfizer Inc, Bristol Myers Squibb SA, Teva Pharmaceuticals USA Inc, Upsher-Smith Laboratories Inc, SMITHFIELD BIOSCIENCE, Opocrin SPA, Bioiberica SA, GSK PLC, Johnson & Johnson Consumer Inc, Fresenius SE & Co KGaA are some of the key players operating in the Global Vasectomy Market.

down-arrow

Cultural stigma and misconceptions, regulatory hurdles, alternative contraceptive methods, are some of the major challenges faced by the Global Vasectomy Market in the upcoming years.

down-arrow

Increasing awareness and education and changing gender dynamics are the major drivers for the Global Vasectomy Market.

profile

Sakshi Bajaal

Business Consultant
Press Release

Vasectomy Market to Grow with a CAGR of 7.65% through 2028

Oct, 2023

Increasing awareness, changing gender dynamics, and cost-effectiveness are expected to drive the Global Vasectomy Market growth in the forecast period, 2024-2028.